Variability of antibiotic susceptibility and toxin production of Staphylococcus aureus strains isolated from skin, soft tissue, and bone related infections

BMC Microbiology

Volumn 13, Issue 1, 2013, Pages

  Sina, Haziz ^a   Ahoyo, Théodora A ^a   Moussaoui, Wardi ^b   Keller, Daniel ^b   Bankolé, Honoré S ^c   Barogui, Yves ^d   Stienstra, Ymkje ^e   Kotchoni, Simeon O ^f   Prévost, Gilles ^b   Baba Moussa, Lamine ^a  

^a UNIVERSITY OF ABOMEY CALAVI   (Benin)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c Section Hygiène des Eaux et Aliments   (Benin)

^d Programme National de Lutte Contre l'Ulcere de Buruli   (Benin)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f RUTGERS UNIVERSITY   (United States)

Author keywords

Africa; Benin; MRSA; Osteomyelitis; PVL; Pyomyositis; S. aureus; Skin infections

Indexed keywords

CEFOXITIN; COTRIMOXAZOLE; ERYTHROMYCIN; EXFOLIATIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; KANAMYCIN; LINCOMYCIN; LINEZOLID; METICILLIN; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; PENICILLIN G; PRISTINAMYCIN; RIFAMPICIN; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN B; STAPHYLOCOCCUS ENTEROTOXIN C; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; TOXIC SHOCK SYNDROME TOXIN 1; VANCOMYCIN;

ABSCESS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BENIN; BURULI ULCER; DISEASE ASSOCIATION; FURUNCULOSIS; GENETIC ANALYSIS; HOSPITAL ADMISSION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOMYELITIS; OUTPATIENT; PYOMYOSITIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BONE DISEASES; HUMANS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84881141439     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-13-188     Document Type: Article

References (71)

1. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Kluytmans A, van Belkum A, Verbrugh H, Clin Microbial Rev 1997 10 3 505 520 (Pubitemid 27359263)
2. Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus. Nubel U, Roumagnac P, Feldkamp M, Song JH, Ko KS, Huang YC, Coombs G, Ip M, Westh H, Skov R, Struelens MJ, Goering RV, Strommenger B, Weller A, Witte W, Achtman M, Proc Natl Acad Sci U S A 2008 105 14130 14135
3. Staphylococcus aureus Isolates Carrying Panton-Valentine Genes in England and Wales: Frequency, Characterization, and Association with Clinical Desease. Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM, J Clin Microbiol 2005 43 5 2384 2390 (Pubitemid 40656255)
4. Virulence factors produced by strains of Staphylococcus aureus isolated from urinary tract infections. Baba-Moussa L, Anani L, Scheftel JM, Couturier M, Riegel P, Haikou N, Hounsou F, Monteil H, Sanni A, Prevost G, J Hosp Infect 2008 68 32 38
5. Toxins and adhesion factors associated with Staphylococcus aureus strains isolated from diarrheal patients in Benin. Baba-Moussa L, Ahissou H, Azokpota P, Assogba B, Atindéhou M, Anagonou S, Keller D, Sanni A, Prévost G, Afr J Biotechnol 2010 9 604 611
6. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Bohach GA, Fast DJ, Nelson RD, Schlievert PM, Crit Rev Microbiol 1990 17 251 272 (Pubitemid 20249880)
7. Bacterial infection of the skin and soft tissues and their treatment. Breneman DL, Curr Opin Infect Dis 1993 6 678 682 (Pubitemid 23282801)
8. Staphylococcal and streptococcal superantigens: their role in human diseases. Murray DL, Ohlendorf DH, Schlievert PM, ASM News 1995 61 229 235
9. Exotoxins of Staphylococcus aureus. Dinges MM, Orwin PM, Schlievert PM, Clin Microbiol Rev 2000 13 16 34 (Pubitemid 30039341)
10. Toxin-mediated syndromes. Barg NL, Harris T, The staphylococci in human disease New York: Churchill Livingstone, Crossley KB, Archer GL, 1997 527 544
11. Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. Durupt F, Mayor L, Bes M, Reverdy ME, Vandenesch F, Thomas L, Etienne J, Br J Dermatol 2007 157 1161 1167 (Pubitemid 350115678)
12. Staphylococcal leucocidins. Gladstone GP, Van Heyningen WE, Br J Exp Pathol 1957 38 123 137
13. Fractionation of a leucocidin from Staphylococcus aureus. Woodin AM, Bioch J 1959 73 225 237
14. Effect of purified staphylococcal leukocidal toxins on isolated blood polymorphonuclear leukocytes and peritoneal macrophages in vitro. Szmigielski S, Sobiczewska E, Prévost G, Monteil H, Colin DA, Jeljaszewicz J, Zentralbl Bakteriol 1998 288 383 394 (Pubitemid 29014600)
15. Phenol-soluble modulin alpha 3 enhances the human neutrophil lysis mediated by Panton- Valentine leukocidin. Hongo I, Baba T, Oishi K, Morimoto Y, Ito T, Hiramatsu K, J Infec Dis 2009 200 715 723
16. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Cribier B, Prevost G, Couppie P, Finck-Barbancon V, Grosshans E, Piemont Y, Dermatology 1992 185 175 180
17. Leucocidin from Staphylococcus aureus and cutaneous infections: an epidemiological study. Couppié P, Cribier B, Prévost G, Grosshans E, Piémont Y, Arch Dermatol 1994 130 1208 1209 (Pubitemid 24288488)
18. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Prevost G, Cribier B, Couppie P, Petiau P, Supersac G, Finck-Barbancon V, Monteil H, Piemont Y, Infect Immun 1995 63 4121 4129
19. Involvement of Panton Valentine leukocidineproducing Staphylococcus aureus in primary skin infections and pneumonia. Lina G, Piémont Y, Godail-Gamot F, Bès M, Peter MO, Gauduchon V, Vandenesh F, Etienne J, Clin Infect Dis 1999 29 1128 1132 (Pubitemid 30265628)
20. Staphylococcal Panton-Valentine leucocidin as a major virulence factor associated to furuncles. Baba-Moussa L, Sina H, Scheftel JM, Moreau B, Sainte-Marie D, Kotchoni SO, Prevost G, Couppie P, PLoS One 2011 6 25716
21. Septicémie à Staphylococcus aureus, furoncle et leucocidine de Panton et Valentine: 3 observations. Couppié P, Hommel D, Prévost G, Godart MC, Moreau B, Sainte- Marie D, Peneau C, Hulin A, Monteil H, Pradinaud R, Ann Dermatol Venereol 1997 124 684 686 (Pubitemid 27488172)
22. Association between Staphylococcus aureus strains carrying gene for Panton Valentin leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piémont Y, Brousse N, Floret D, Etienne J, Lancet 2002 359 753 759 (Pubitemid 34215075)
23. Staphylococcus aureus Panton Valentine leukocidin causes necrotizing pneumonia. Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M, Benito Y, Barbu EM, Vazquez V, Höök M, Etienne J, Vandenesch F, Bowden MG, Science 2007 315 5815 1130 1133 (Pubitemid 46328024)
24. Contribution of Panton Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Diep BA, Palazzolo-Ballance AM, Tattevin P, Basuino L, Braughton KR, Whitney AR, Chen L, Kreiswirth BN, Otto M, DeLeo FR, Chambers HF, PLos One 2008 3 3198
25. Osteoarticular infections with Staphylococcus aureus secreting Panton Valentine leucocidin. Gillet Y, Dohin B, Dumitrescu O, Lina G, Vandenesch F, Etienne J, Floret D, Arch Pediatr 2007 14 Suppl 2 102 107
26. Purpura fulminans in a child secondary to Panton Valentine leukocidinproducing Staphylococcus aureus. Hussain A, Robinson GO, Malkin J, Duthie M, Kearns A, Perera N, J Med Microbiol 2007 56 1407 1409 (Pubitemid 350105613)
27. Infection by Panton Valentine leukocidin-producing Staphylococcus aureus clinically mimicking Lemierre's syndrome. Shivashankar GH, Murukesh N, Varma MP, Sharif IM, Glynn G, J Med Microbiol 2008 57 118 120
28. Community-acquired methicillin resistant Staphylococcus aureus as a cause of Fournier's gangrene. Burton MJ, Shah P, Swiatlo E, J Med Sci 2008 335 327 328 (Pubitemid 351548656)
29. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Dumitrescu O, Boisset S, Badiou C, Bes M, Benito Y, Reverdy ME, Vandenesch F, Etienne J, Lina G, Antimicrob Agents Chemother 2007 51 1515 1519 (Pubitemid 46586841)
30. Community-associated meticillin-resistant Staphylococcus aureus. Deleo FR, Otto M, Kreiswirth BN, Chambers HF, Lancet 2010 375 1557 1568
31. The evolution of Staphylococcus aureus. Deurenberg RH, Stobberingh EE, Inf Genet Evol 2008 8 747 763
32. Relationship between Vancomycin-Resistant Staphylococcus aureus, Vancomycin-Intermediate S. aureus, High Vancomycin MIC, and Outcome in Serious S. aureus Infections. Holmes NE, Johnson PD, Howden BP, J Clin Microbiol 2012 50 2548 2552
33. Dissemination in Japanese hospitals of strains of S. aureus heterogeneously resistant to vancomycin. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Kobayashi I, Lancet 1997 350 1670 1673 (Pubitemid 28036828)
34. The EPISA Study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland. Denton M, O'Connell B, Bernard P, Jarlier V, Wiliams Z, Santerre Henriksen A, J Antimicrobial Chemother 2008 61 3 586 588 (Pubitemid 351321131)
35. Activité de 16 Antibiotiques vis-à-vis des Staphylococcus aureus communautaires à Casablanca (Maroc) et Prévalence des Souches Résistantes à la Méthicilline. Elazhari M, Saile R, Dersi N, Timinouni M, Elmalki A, Zriouil SB, Hassar M, Zerouali K, Eur J Sci Res 2009 30 128 137
36. Epidemiology of drug resistance: implications for a post-antimicrobial era. Cohen ML, Science 1992 257 1050 1055
37. Antibiotic susceptibility and Toxins production of Staphylococcus aureus isolated from clinical samples from Benin. Sina H, Baba-Moussa F, Ahoyo TA, Mousse W, Anagonou S, Gbenou JD, Prévost G, Kotchoni SO, Baba-Moussa L, Afr J Microbiol Res 2011 5 2797 2808
38. In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar. Randrianirina F, Soares JL, Ratsima E, Carod JF, Combe P, Grosjean P, Richard V, Talarmin A, Ann Clin Microbiol Antimicrob 2007 6 5
39. Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta. Kesah C, Ben Redjeb S, Odugbemi TO, Boye CS, Dosso M, Ndinya Achola JO, Koulla-Shiro S, Benbachir M, Rahal K, Borg M, Clin Microbiol Infect 2003 9 153 156 (Pubitemid 36527062)
40. Approche épidémiologique de l'antibiorésistance et de la production de leucotoxines par les souches de Staphylococcus aureus isolées en Afrique de l'Ouest. Baba-Moussa L, Sanni A, Dagnra AY, Anagonou S, Prince-David M, Edoh V, Befort JJ, Prévost G, Monteil H, Med Mal Infect 1999 29 11 689 696
41. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, Clin Infect Dis 2001 32 suppl 2 114 132
42. Résistance de Staphylococcus aureus isolé des infections communautaires et hospitalieres à Casablanca. Belabbès H, Elmdaghri N, Hachimi K, Marih L, Zerouali K, Benbachir M, Communication brève. Med Mal Infect 2001 31 25 28 (Pubitemid 32174319)
43. Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. Maor Y, Hagin M, Belausov N, Keller N, Ben-David D, Rahav G, J Infect Dis 2009 199 619 624
44. Prevalence and Antibiotic susceptibility pattern of Panton-Valentine Leucocidin (PVL) positive Staphylococcus aureus Strains from clinical specimens in Northeastern Nigeria. Okon KO, Uba A, Oyawoye OM, Yusuf IZ, Adesina OO, Sierra Leone J Biomed Res 2012 4 1 43 52
45. Unusually high prevalence of nosocomial Panton-Valentine leukocidin -positive Staphylococcus aureus isolates in Cape Verdes Island. Aires de Sousa M, Conceicao T, de Lancastre H, J Clin Microbiol 2006 44 37 3793
46. Genotypic characterization of Staphylococcus aureus isolates from a multinational trial of topical drugs for skin and skin stricture infections. Campbell SJ, Deshmukl HS, Nelson CL, Bae I, J Clin Microbiol 2008 46 678 684 (Pubitemid 351231317)
47. Molecular epidemiology of methicillin-resistant and methicillin- susceptible Staphylococcus aureus isolates from global clinical trial. Goering RV, Shawar RM, Scangarella NE, OHara FP, Amrine-Madsen H, West JM, Dalessandro M, Becker JA, Walsh SL, Miller LA, van Horn SF, Thomas ES, Twynholm T, J Clin Microbiol 2008 9 2842 2847
48. Staphylococcal pore-forming toxins. Prévost G, Mourey L, Colin DA, Menestrina G, Curr Top Microbiol Immunol 2001 257 53 83 (Pubitemid 32230025)
49. Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. Genestier AL, Michallet MC, Prevost G, Bellot G, Chalabreysse L, Peyrol S, Thivolet F, Etienne J, Lina G, Vallette FM, Vandenesch F, Genestier L, J Clin Invest 2005 115 3117 3127 (Pubitemid 41567576)
50. Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus. Ladhani S, FEMS Immunol Med Microbiol 2003 39 181 189 (Pubitemid 37415084)
51. Prevost G, Couppie P, Monteil H, Staphylococcal epidermolysins. Curr Opin Infect Dis 2003 16 71 76
52. Community acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J, Emerg Infect Dis 2003 9 978 984 (Pubitemid 36944519)
53. Food-poisoning due to staphylococcal enterotoxin E. Morris CA, Conway HD, Everall PH, Lancet 1972 2 1375 1376
54. Use of Novel PCR Primers Specific to the Genes of Staphylococcal Enterotoxin G, H, I for the Survey of Staphylococcus aureus Strains Isolated From Food-Poisoning Cases and Food Samples in Taiwan. Chen TR, Chiou CS, Tsen HY, Int J Food Microbiol 2004 92 189 197
55. Mass Outbreak of Food Poisoning Disease Caused by Small Amounts of Staphylococcal Enterotoxins A and H. Ikeda T, Tamate N, Yamaguchi K, Makino S, Appl Environ Microbiol 2005 71 2793 2795 (Pubitemid 40647030)
56. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. Daum RS, Ito T, Hiramatsu K, Hussain F, Mongkolrattanothai K, Jamklang M, Boyle-Vavra S, J Infect Dis 2002 186 1344 1347 (Pubitemid 35193015)
57. Comparison of com-munity- and health care-associated methicillin- resistant Staphylococcus aureus infection. Naimi TS, LeDell KH, Como-Sabetti K, et al. JAMA 2003 290 2976 2984 (Pubitemid 37505530)
58. Emergence of com-munity-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Buckingham SC, McDougal LK, Cathey LD, et al. Pediatr Infect Dis J 2004 23 619 624 (Pubitemid 38924885)
59. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y, Clin Infect Dis 2003 36 53 59 (Pubitemid 36099097)
60. A New Staphylococcal Enterotoxin, Enterotoxin F, Associated with Toxic-Shock-Syndrome Staphylococcus aureus Isolates. Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP, Lancet 1981 1 1017 1021 (Pubitemid 11096622)
61. Panton-Valentine Leukocidin associated with community acquired methicillin resistant Staphylococcus aureus: a case report and review of interim guidelines. Baldwin LN, Lowe AD, Anaesthesia 2008 63 764 766 (Pubitemid 351814233)
62. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Chambers HF, Clin Microbiol Rev 1997 10 781 791 (Pubitemid 27477734)
63. Consequences of the interaction of beta-lactam antibiotics with penicillin binding proteins from sensitive and resistant Staphylococcus aureus strains. Labischinski H, Med Microbiol Immunol 1992 181 241 265
64. Cheesbrough M, District Laboratory Practice in Tropical Countries: Part 2 Cambridge, UK: Cambridge University Press 2004 299 329
65. Société Française de Microbiologie, Recommandations du Comité de l'Antibiogramme de la Société Française de Microbiologie 2012 http://www.sfm-microbiologie.org/UserFiles/file/CASFM/ CASFM-2012.pdf
66. Clinical and Laboratory Standards Institute, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved standard Document M7-A8. Clinical and Laboratory Standards Institute Wayne: PA 8 ISBN 1-56238-689-1 2009
67. Flow cytometric determination of Panton-Valentine leucocidin S component binding. Gauduchon V, Werner S, Prévost G, Monteil H, Colin DA, Infect Immun 2001 69 2390 2395 (Pubitemid 32239708)
68. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. Prévost G, Couppie P, Prévost P, Gayet S, Petiau P, Cribier B, Monteil H, Piemont Y, J Med Microbiol 1995 42 237 245
69. Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. Gravet A, Colin DA, Keller D, Girardot R, Monteil H, Prevost G, FEBS Lett 1998 436 202 208 (Pubitemid 28468556)
70. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, Nesme X, Etienne J, Vandenesch F, Infect Immun 2002 70 631 641 (Pubitemid 34083822)
71. Sensitive and specific detection of staphylococcal epidermolysins A and B in broth cultures by flow cytometry-assisted multiplex immunoassay. Joubert O, Keller D, Pinck A, Monteil H, Prevost G, J Clin Microbiol 2005 43 1076 1080 (Pubitemid 40364921)